Literatur
-
1
Engelmann G, Gebhardt C, Wenning D et al.
Feasibility study and control values of transient elastography in healthy children.
Eur J Pediatr.
2011;
23
[epub ahead of print]
-
2
Murawaki Y, Ikuta Y, Okamoto K et al.
Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.
J Gastroenterol.
2001;
36
399-406
-
3
Leroy V, Monier F, Bottari S et al.
Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Am J Gastroenterol.
2004;
99
271-279
-
4
Wai C T, Greenson J K, Fontana R J et al.
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
Hepatology.
2003;
38
518-526
-
5
Imbert-Bismut F, Ratziu V, Pieroni L et al.
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Lancet.
2001;
357
1069-1075
-
6
Franzese A, Iorio R, Buono P et al.
Mauriac syndrome still exists.
Diabetes Res Clin Pract.
2001;
54
219-221
-
7
Kim M S, Quintos J B.
Mauriac syndrome: growth failure and type 1 diabetes mellitus.
Pediatr Endocrinol Rev.
2008;
5 (Suppl. 4)
989-993
-
8
Bravo A A, Sheth S G, Chopra S.
Liver biopsy.
N Engl J Med.
2001;
344
495-500
Dr. med. Guido Engelmann
Zentrum für Kinder- und Jugendmedizin, Klinik 1
Universitätsklinikum Heidelberg
Im Neuenheimer Feld 430
69120 Heidelberg
Email: Guido.Engelmann@med.uni-heidelberg.de
